Table 2.
Novel ECG Parameters for Cardiac Organ Damage
| Parameters | Overall (N=50) | Normotensive (n=18) | Hypertensive (n=32) | P Value |
|---|---|---|---|---|
| Tp‐Te, mm | 2.7015±0.577 | 2.2234±0.32531 | 2.9554±0.52002 | <.001 |
| VAT, mm | 0.9930±0.1836 | 0.9786±.1973843 | 1.0008±0.178492 | .693 |
| P‐wave duration | ||||
| DI | 2.2123±0.5331 | 2.1368±0.6221 | 2.2525±0.4853 | .475 |
| DII | 2.6377±0.3987 | 2.5759±0.3839 | 2.6706±0.4085 | .435 |
| DIII | 2.1921±0.5995 | 2.3756±0.3977 | 2.0945±0.6683 | .119 |
| aVR | 2.4751±0.3936 | 2.3654±0.3652 | 2.5333±0.4012 | .157 |
| aVL | 1.7968±0.5116 | 1.9925±0.3987 | 1.6929±0.5395 | .050 |
| aVF | 2.4179±0.5493 | 2.3195±0.5618 | 2.4702±0.5442 | .336 |
| V1 | 2.0581±0.5057 | 2.0049±0.4399 | 2.0863±0.5419 | .597 |
| V2 | 1.8437±0.4073 | 1.7631±0.3924 | 1.8866±0.4147 | .317 |
| V3 | 2.1528±0.4752 | 2.0175±0.4226 | 2.2247±0.4921 | .148 |
| V4 | 2.4795±0.4540 | 2.3338±0.5178 | 2.5569±0.4036 | .102 |
| V5 | 2.5048±0.5067 | 2.4618±0.5272 | 2.5276±0.5026 | .670 |
| V6 | 2.5105±0.5149 | 2.4758±0.5549 | 2.5290±0.5006 | .734 |
| Maximum duration | 2.9699±0.4043 | 2.8653±0.3903 | 3.0254±0.4066 | .190 |
| Minimum duration | 1.3784±0.3249 | 1.4485±0.3374 | 1.3412±0.3172 | .276 |
| Average duration | 2.2285±0.2892 | 2.2332±0.2824 | 2.2260±0.2971 | .934 |
| P‐wave dispersion | 1.5027±0.4387 | 1.4126±0.4288 | 1.5505±0.4431 | .300 |
| P‐wave area | 2.0900±0.7746 | 2.1524±0.8706 | 2.0568±0.7311 | .685 |
| P‐wave amplitude (DIII) | 1.5652±0.5401 | 1.6455±0.6326 | 1.5226±0.4896 | .454 |
Abbreviations: ECG, electrocardographic; VAT, ventricular activation time.